Aug 6, 2026 02:24AM
Aug 5, 2026 07:00AM
Jul 13, 2026 08:03AM
Jul 13, 2026 08:00AM
Jun 2, 2026 12:32PM
May 7, 2026 07:00AM
Feb 18, 2026 07:00AM Charles River Laboratories Announces Fourth-Quarter and Full-Year 2025 Results and Provides 2026 Guidance
Jan 12, 2026 04:30PM
Jan 12, 2026 04:30PM
Jan 8, 2026 08:02AM
Jan 8, 2026 08:00AM
Nov 5, 2025 07:00AM
Sep 16, 2025 07:05AM
Sep 16, 2025 07:05AM Charles River Laboratories Announces Chief Financial Officer Transition
Aug 6, 2025 07:00AM
Jul 22, 2025 08:00AM
May 7, 2025 07:01AM
May 7, 2025 07:01AM
May 7, 2025 07:00AM
Apr 29, 2025 08:00AM
Feb 19, 2025 07:00AM Charles River Laboratories Announces Fourth-Quarter and Full-Year 2024 Results and Provides 2025 Guidance
Jan 16, 2025 08:00AM
Jan 14, 2025 09:37AM
Jan 14, 2025 08:10AM
Nov 6, 2024 07:00AM
Aug 7, 2024 07:00AM
Jul 30, 2024 08:04AM
Jul 30, 2024 08:00AM Charles River Collaborates with Patient Advocacy Group, FOXG1 Research Foundation to Advance Rare Disease Gene Therapy Development
Jun 25, 2024 08:00AM
Jun 17, 2024 08:00AM
Jun 13, 2024 06:28AM
May 9, 2024 07:00AM
Apr 4, 2024 08:00AM
Feb 14, 2024 07:00AM
Nov 8, 2023 07:00AM Charles River Laboratories Announces Third-Quarter 2023 Results
Aug 9, 2023 07:00AM
Jul 16, 2023 09:30PM
Jul 10, 2023 09:00PM
Jul 5, 2023 09:00PM
Jun 25, 2023 09:00PM
Jun 19, 2023 09:00PM
Jun 4, 2023 09:00PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Stem, Disney, and Charles River and Encourages Investors to Contact the Firm
May 30, 2023 09:00PM
May 24, 2023 09:00PM
May 11, 2023 07:00AM
Feb 22, 2023 07:00AM
Jan 30, 2023 07:03AM
Jan 30, 2023 07:00AM
Jan 5, 2023 10:17AM Arlington Capital Partners Announces the Acquisition of AVS Bio
Dec 12, 2022 04:37PM

1,178,426 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All